The number of included studies in the meta-analysis was limited and inclusion of further recent studies in Asian populations, like Iran and Egypt, led to significant association of MPP9 polymorphism with MS susceptibility. This evidence concerns the gene MPHOSPH9 and myeloid sarcoma.